{"success":true,"data":{"pressRelease":{"id":"21925","rtpr_id":"nGNX15Vx6X","ticker":"IRIX","exchange":"NASDAQ","all_tickers":["IRIX"],"title":"Iridex to Report First Quarter 2026 Financial Results on May 19, 2026","author":"Globe Newswire","published_at":"2026-05-05T20:05:02.215Z","article_body":"MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation\n(Nasdaq: IRIX), a worldwide leader providing innovative and versatile\nlaser-based medical systems, delivery devices, and accessories for the\ntreatment of glaucoma and retinal diseases, today announced plans to release\nfinancial results for the first quarter 2026 and provide a business update\nafter the close of trading on May 19, 2026.\n\nThe Company’s management team will host a corresponding conference call\nbeginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to\nthe conference call may do so by dialing +1-646-307-1963 from the US or\n+1-800-715-9871 internationally and providing Conference ID: 9329659. A live\nand recorded webcast will be available on the “Event Calendar” page of the\n“Investors” section of the Company’s website at www.iridex.com.\n\nAbout Iridex Corporation \nIridex Corporation is a worldwide leader in developing, manufacturing, and\nmarketing innovative and versatile laser-based medical systems, delivery\ndevices, and accessories for the ophthalmology market. The Company’s\ntechnologies are used in the treatment of glaucoma, diabetic macular edema,\nand other retinal diseases. Iridex products are sold in the United States\nthrough a direct sales force and internationally primarily through a network\nof independent distributors into more than 100 countries.\n\nInvestor Relations Contact\nPhilip Taylor\nGilmartin Group\ninvestors@iridex.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2bb80159-a920-428b-aa69-c2f32e3038c9)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX15Vx6X","title":"Iridex to Report First Quarter 2026 Financial Results on May 19, 2026","author":"Globe Newswire","ticker":"IRIX","created":"2026-05-05T20:05:02.215Z","tickers":["IRIX"],"exchange":"NASDAQ","article_body":"MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation\n(Nasdaq: IRIX), a worldwide leader providing innovative and versatile\nlaser-based medical systems, delivery devices, and accessories for the\ntreatment of glaucoma and retinal diseases, today announced plans to release\nfinancial results for the first quarter 2026 and provide a business update\nafter the close of trading on May 19, 2026.\n\nThe Company’s management team will host a corresponding conference call\nbeginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to\nthe conference call may do so by dialing +1-646-307-1963 from the US or\n+1-800-715-9871 internationally and providing Conference ID: 9329659. A live\nand recorded webcast will be available on the “Event Calendar” page of the\n“Investors” section of the Company’s website at www.iridex.com.\n\nAbout Iridex Corporation \nIridex Corporation is a worldwide leader in developing, manufacturing, and\nmarketing innovative and versatile laser-based medical systems, delivery\ndevices, and accessories for the ophthalmology market. The Company’s\ntechnologies are used in the treatment of glaucoma, diabetic macular edema,\nand other retinal diseases. Iridex products are sold in the United States\nthrough a direct sales force and internationally primarily through a network\nof independent distributors into more than 100 countries.\n\nInvestor Relations Contact\nPhilip Taylor\nGilmartin Group\ninvestors@iridex.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2bb80159-a920-428b-aa69-c2f32e3038c9)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-05T20:05:02.876438915Z","server_sent_at_ms":1778011502876},"received_at":"2026-05-05T20:05:02.928Z","source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263410/0/en/iridex-reports-fourth-quarter-and-full-year-2025-financial-results.html"},"analysis":{"id":"16306","press_release_id":"21925","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Iridex announced it will release its first quarter 2026 financial results after the market close on May 19, 2026.\n\nManagement is scheduled to host a conference call at 2:00 p.m. PT to discuss the results and provide a business update.\n\nInvestors can access the call via dial-in or a live webcast available on the company’s website.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Earnings calendar update only; no material news."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Philip Taylor","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"Iridex Corporation","ticker":"IRIX"},{"name":"Gilmartin Group","relationship":"investor relations firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine earnings calendar announcement. The release contains no financial results, guidance, or material business updates, only the scheduling of a future conference call."},"tickerRelevance":{"others":[],"primary":"IRIX"},"globalImportance":5,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings-calendar-announcement"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Iridex announced it will release its first quarter 2026 financial results after the market close on May 19, 2026.\n\nManagement is scheduled to host a conference call at 2:00 p.m. PT to discuss the results and provide a business update.\n\nInvestors can access the call via dial-in or a live webcast available on the company’s website.","key_figures":{},"named_entities":{"people":[{"name":"Philip Taylor","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"Iridex Corporation","ticker":"IRIX"},{"name":"Gilmartin Group","relationship":"investor relations firm"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:511026a279f8af46","schema_hash":"sha256:96555d0809de301c","created_at":"2026-05-06T02:42:47.648Z","global_importance":5,"audience_relevance":5,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings-calendar-announcement"}},"durationMs":32653,"modelName":"glm-4.7"}}